RenovoRx RNXT
NASDAQ RNXT
$1.25 +0.05 (+4.58%)
As of: Oct 21, 2026 · 1:45 PM EDT

RenovoRx (RNXT) Notes Payables (2020)

Updated

RenovoRx's Notes Payables came in at $2.65 million for Q4 2020.

Analysis

RenovoRx (RNXT) Notes Payables (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.41 Bn 237.44 Bn 4.88 Bn
2 Abbott Laboratories 171.78 Bn 142.21 Bn 7.27 Bn
3 Danaher 162.52 Bn 146.33 Bn 3.61 Bn
4 Intuitive Surgical 151.13 Bn 130.55 Bn 1.96 Bn
5 Medtronic 119.73 Bn 84.98 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.01 Bn 4.50 Bn
7 Boston Scientific 65.34 Bn 60.10 Bn 3.85 Bn
8 Becton Dickinson 53.50 Bn 50.65 Bn 2.32 Bn
9 Edwards Lifesciences 50.91 Bn 34.92 Bn 1.35 Bn
10 RenovoRx 59.36 Mn 20.39 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2.65 Mn
API Access

RenovoRx Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RNXT&period=max&api_key=YOUR_API_KEY